Autolus Therapeutics plc (ADR)

General ticker "AUTL" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $504.8M (TTM average)

Autolus Therapeutics plc (ADR) follows the US Stock Market performance with the rate: 8.4%.

Estimated limits based on current volatility of 3.9%: low 1.33$, high 1.44$

Factors to consider:

  • Total employees count: 471 as of 2023
  • US accounted for 79.6% of revenue in the fiscal year ended 2023-12-31
  • Top business risk factors: Operational and conduct risks, Limited operating history, Labor/talent shortage/retention, Geopolitical risks, Currency fluctuations
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [0.94$, 2.67$]
  • 2026-12-31 to 2027-12-31 estimated range: [1.19$, 3.14$]

Similar symbols

Short-term AUTL quotes

Long-term AUTL plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $9.90MM $75.56MM
Operating Expenses $179.70MM $251.32MM $357.00MM
Operating Income $-179.70MM $-241.43MM $-281.44MM
Non-Operating Income $-28.70MM $22.29MM $-15.41MM
Interest Expense $45.07MM $9.29MM $36.76MM
R&D Expense $130.48MM $138.44MM $117.69MM
Income(Loss) $-208.40MM $-219.13MM $-296.85MM
Taxes $-0.02MM $1.53MM $-1.97MM
Profit(Loss)* $-208.38MM $-220.66MM $-287.53MM
Stockholders Equity $111.47MM $427.32MM $178.13MM
Inventory $0.00MM $4.14MM $33.21MM
Assets $375.38MM $782.73MM $589.07MM
Operating Cash Flow $-145.59MM $-206.27MM $-283.57MM
Capital expenditure $10.99MM $34.82MM $19.09MM
Investing Cash Flow $-10.99MM $-394.55MM $158.46MM
Financing Cash Flow $-0.88MM $589.55MM $-4.34MM
Earnings Per Share** $-1.20 $-0.86 $-1.08
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.